Glaspy JA, Marcus S, Ambcrslcy J, Golde DW. Recombinant beta serine interferon in hairy cell 
leukemia, compared prospectively to results with recombinant alpha interferon. Cancer 64:409-417 
1989. 
9. Glaspy JA, Golde DW. Clinical applications of the myeloid growth factors. Seminars in Hematology, 
26:14-17 1989. 
10. Glaspy JA, Management of breast cancer; changes with age. Stage JV decisions. Intensive course in 
geriatric medicine syllabus, American College of Physicians, pp 159-162, 1989. 
11. Glaspy JA, Golde DW. Hie hematopoietic growth factors, biology and clinical use. Oncology 4:(no.9), 
25-32, 1990. 
1 2. Golde DW, Glaspy JA. Clinical applications of the colony-stimulating factors. In: Hematology , 4th ed. 
Williams WJctal.cds. McGrawHill. pp273-279, 1990. 
13. Miles SA, Mitsuyasu RT, Lee K, Glaspy JA. Recombinant human granulocyte, colony stimulation 
factor increases burst forming units crythroid in the peripheral blood of patients with acquired immune 
deficiency syndrome. Blood 75:2137-2142, 1990. 
14. Miles SA, Mitsuyasu RT, Moreno J, Alton K, Souza L, Glaspy JA. Combined therapy with recombinant 
G-CSF and EPO decreases hematologic toxicity from zidovudine. Blood 77:2109-21 17, 1991. 
1 5. Roberts RL, Szelc CM, Scutes SM, Boyd MT, Soderstrom KM, Davis MW, Glaspy JA. Neutropenia in 
an extremely premature infant treated with recombinant human granulocyte colony stimulating factor. 
Amer J Disease Children 145:808-812, 1991. 
1 6. Crawford J, Ozer H, Stoller R, Johnson D, Lyman G. Tabbara I, Kris M. Gratis J, Picozzi V. Rausch G, 
Smith R, Gradishar W, Yahanda A, Vincent M, Stewart M, Glaspy JA. Reduction by granulocyte 
colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell 
lung cancer. N. Eng J Med 325:164-170, 1991. 
17. Hawkins RA, Hoh C, Dahlbom M. Choi Y, Glaspy JA, Tse N, Slant on D, Chen B, Messa C, Maddahi J, 
Phelps ME. PET cancer evaluations with FDG. J Nuc Med 32:1555-1557, 1991 . 
18. Tse NY, Hoh CK, Hawkins RA, Zinncr MJ, Dahlborn M, Choi Y, Maddahi J. Bruniourdi FC, 
Phelps ME, Glaspy JA. The Application of Positron Emission Tomographic Imaging with 
FI uorodeoxy glucose to the Evaluation of Breast Disease. Annals of Surgery, in press 1992. 
19. Schiepcrs C, Hawkins RA, Hoh C, Glaspy JA, Shimon D, Dahlbom M, Hoffman EF, Chen B, Huang 
SC. Choi Y, Phelps ME. Total body imaging with lluorodeoxygluco.se (FDG) and PET in patients with 
malignancies. JNuc Med 31:893, 1990 (abstract). 
20. Hoh CK, Hawkins RA, Dahlbom M, Phelps ME, Glaspy JA, Slamon D, Choi Y, Chen B, Hoffman EJ, 
Guerrero TM. Total body metabolic imaging in cancer patients with PET: Impact on medical 
management. Proceedings, Radiological Society of North American and American Association of 
Physicists in Medicine. Radiology 177:198 (#671), 1990 (abstract). 
21 . Hoh CK, i lawkins RA, Glaspy JA, et al. PET total body imaging of breast cancer with F-'l 8 ion and 
FDG. Clin Nucl Medicine 15:763, 1990 (abstract). 
22. Hoh CK, Maddahi J, Glaspy JA, Slamon D, Dahlbom M, Choi Y, Chen BC, Phelps ME, Hawkins RA. 
PET total body imaging of breast cancer with FDG and F-l 8 ion. J Blue Med 32:981, 1991 (abstract). 
23. Hoh CK, Maddahi J, Glaspy JA, Choi Y, Dahlbom M, Chen BC, Schiepers CW, Phelps ME, Hawkins 
RA. Total body imaging of tumors of the abdomen and pelvis with FDG. J Nuc Med 32;982, 1991 
(abstract). 
24. Hoh CK, Hawkins RA, Dahlbom M, Glaspy JA, Tse N, Maddahi ,T, Phelps ME: Whole body metabolic 
imaging with PET FDG in patients with breast carcinoma. Presented ut the 77th Scientific Assembly and 
Annual Meeting of the Radiological Society of North America, Chicago. December 1-6, 1991. 
Radiology 181 (P): 199, 1991. 
25. Hoh CK, Hawkins RA, Dahlbom M, Glaspy JA, Aberle D, Maddahi J, Phelps ME. Whole body 
metabolic imaging of the chest in patients with carcinoma. Presented at the 77th Scientific Assembly and 
Annual Meeting of the Radiological Society of North America, Chicago, December 1-6. 1991. 
Radiology 181 (P): 200, 1991. 
26. Tse N, Ho CK, 1 lawkins RA, Dahlbom M. Phelps ME, Glaspy JA: The UCLA experience with whole 
body positron emission scanning in breast cancer. Proceedings, American Society of Clinical Oncology 
(in press). 
27. Jacobs E, llo C, Gasson J, Baldwin G, Phelps ME, Hawkins R, Glaspy J: Changes in glucose metabolic 
activity during therapy with GM-CSF in melanoma meta stases evaluated in vovo using positron 
emission tomography (PET). Proceedings, American Society ■ of Clinical Oncology (in press). 
Recombinant DNA Research, Volume 18 
[442] 
